Blockchain Registration Transaction Record

United Health Products Partners with NAMSA for CelluSTAT Study

United Health Products partners with NAMSA to conduct a clinical study of CelluSTAT Hemostatic Gauze, aiming for FDA approval and market entry in surgical bleeding control.

This partnership is crucial because it advances the clinical validation of CelluSTAT, a hemostatic gauze that could offer a safe, all-natural alternative for controlling bleeding in surgeries. For patients and healthcare providers, successful FDA approval would mean access to a new tool that may reduce complications from bleeding, improving surgical outcomes and potentially saving lives. Investors should note that this collaboration de-risks the regulatory process, as NAMSA's expertise increases the likelihood of a successful study and eventual market entry.